α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 30 março 2025

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action - ScienceDirect

Labetalol - an overview

Targeting of G-protein coupled receptors in sepsis - ScienceDirect

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

Adrenergic Nervous System in Heart Failure

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Atherosclerosis: lessons from LXR and the intestine: Trends in Endocrinology & Metabolism

What Is the Role of β-Adrenergic Signaling in Heart Failure?

Pcol Cover To Cover, PDF, Angiotensin

Recomendado para você